Intermittent androgen deprivation therapy in prostate cancer treatment: long-term multi-centre study results

Date Posted: 
2012-08-13

A new study co-authored by Dr. Larry Goldenberg, urologic surgeon and researcher at the Vancouver Prostate Centre and head of the Department Urologic Sciences at UBC, has shown that prostate cancer patients who are given a “drug holiday” have the same survival rate as the continuous treatment group, and a far better quality of life.

Vancouver Coastal Health researchers and clinicians at the Vancouver Prostate Centre are pioneers in this field, having begun research and treatment of patients with intermittent therapy since the 1990s. The Centre has been an epicenter for this form of treatment and results from this large-scale study confirm earlier research. The study, which was published in New England Journal of Medicine (September 6, 2012), is expected to impact changes in prostate cancer protocols at other centres across Canada and worldwide.

Click here for more information and here for the reference at New England Journal of Medicine.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Movember Foundation 2018

Movember 2018

The Movember Foundation's fundraiser runs from November 1 to 30.  Click here to donate to The Vancouver Prostate Centre team as we join teams across Canada to raise funds for men's health research in the areas of prostate cancer, testicular cancer, mental health and suicide prevention.

Employment

Work at the Vancouver Prostate Centre

Tuesday, November 27, 2018

An innovative new study advances personalized medicine for prostate cancer patients

Drs Chi and Wyatt
Tuesday, October 23, 2018

Three researchers receive Prostate Cancer Canada & Movember Foundation grants for biomarker development